APA (7th ed.) Citation

Galon, J., Hermitte, F., Mlecnik, B., Marliot, F., Bifulco, C., Lugli, A., . . . Pagès, F. (2019). 78OImmunoscore predicts significant differences in time to recurrence in stage I colon cancer patients. Annals of Oncology, 30, N.PAG. https://doi.org/10.1093/annonc/mdz421

Chicago Style (17th ed.) Citation

Galon, J., et al. "78OImmunoscore Predicts Significant Differences in Time to Recurrence in Stage I Colon Cancer Patients." Annals of Oncology 30 (2019): N.PAG. https://doi.org/10.1093/annonc/mdz421.

MLA (9th ed.) Citation

Galon, J., et al. "78OImmunoscore Predicts Significant Differences in Time to Recurrence in Stage I Colon Cancer Patients." Annals of Oncology, vol. 30, 2019, p. N.PAG, https://doi.org/10.1093/annonc/mdz421.